Literature DB >> 26238742

Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System.

Julius Gene S Latorre1, Elena B Schmidt.   

Abstract

No compound has generated more attention in both the scientific and recently in the political arena as much as cannabinoids. These diverse groups of compounds referred collectively as cannabinoids have both been vilified due to its dramatic and potentially harmful psychotropic effects and glorified due to its equally dramatic and potential application in a number of acute and chronic neurological conditions. Previously illegal to possess, cannabis, the plant where natural form of cannabinoids are derived, is now accepted in a growing number of states for medicinal purpose, and some even for recreational use, increasing opportunities for more scientific experimentation. The purpose of this review is to summarize the growing body of literature on cannabinoids and to present an overview of our current state of knowledge of the human endocannabinoid system in the hope of defining the future of cannabinoids and its potential applications in disorders of the central nervous system, focusing on stroke.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26238742     DOI: 10.1007/s11886-015-0627-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  42 in total

Review 1.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  High hopes for CB(2) receptors in neurogenesis.

Authors:  Eric J Downer
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra.

Authors:  Clemens Sommer; Markus Schomacher; Christian Berger; Katharina Kuhnert; Harald D Müller; Stefan Schwab; Wolf-Rüdiger Schäbitz
Journal:  Acta Neuropathol       Date:  2006-07-27       Impact factor: 17.088

Review 4.  Safety and side effects of cannabidiol, a Cannabis sativa constituent.

Authors:  Mateus Machado Bergamaschi; Regina Helena Costa Queiroz; Antonio Waldo Zuardi; José Alexandre S Crippa
Journal:  Curr Drug Saf       Date:  2011-09-01

5.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

Review 6.  Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.

Authors:  Roger G Pertwee
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 7.  Endocannabinoid system in food intake and metabolic regulation.

Authors:  David Jesudason; Gary Wittert
Journal:  Curr Opin Lipidol       Date:  2008-08       Impact factor: 4.776

8.  Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.

Authors:  Cory S Freedland; Christopher T Whitlow; Mack D Miller; Linda J Porrino
Journal:  Synapse       Date:  2002-08       Impact factor: 2.562

Review 9.  Is the cardiovascular system a therapeutic target for cannabidiol?

Authors:  Christopher P Stanley; William H Hind; Saoirse E O'Sullivan
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 10.  Vascular targets for cannabinoids: animal and human studies.

Authors:  Christopher Stanley; Saoirse E O'Sullivan
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more
  6 in total

Review 1.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

2.  Association between recent cannabinoid use and acute ischemic stroke.

Authors:  Carmela V San Luis; Christa O'Hana S Nobleza; Shashank Shekhar; Rebecca Sugg; Darren J Villareal; Tapan Mehta; Shreyas Gangadhara
Journal:  Neurol Clin Pract       Date:  2020-08

Review 3.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

4.  Cannabis Therapeutics and the Future of Neurology.

Authors:  Ethan B Russo
Journal:  Front Integr Neurosci       Date:  2018-10-18

5.  Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.

Authors:  Kun Wang; Qian Wang; Qinghao Li; Zhaoqiang Zhang; Jing Gao; Cundong Fan; Baoliang Sun; Qingbin Ni
Journal:  Biomed Res Int       Date:  2021-04-22       Impact factor: 3.411

Review 6.  Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions.

Authors:  Abbas Jarrahi; Molly Braun; Meenakshi Ahluwalia; Rohan V Gupta; Michael Wilson; Stephanie Munie; Pankaj Ahluwalia; John R Vender; Fernando L Vale; Krishnan M Dhandapani; Kumar Vaibhav
Journal:  Biomedicines       Date:  2020-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.